
==== Front
Dent Res J (Isfahan)
Dent Res J (Isfahan)
DRJ
Dent Res J
Dental Research Journal
1735-3327
2008-0255
Wolters Kluwer - Medknow India

DRJ-21-11
Original Article
Evaluation of taste score and fungiform papillae quantification using digital image analysis in COVID-19 patients with smell and taste dysfunction
Srikantaiah Vidya Chikkarahalli 1
Bilimale Anil Somashekara 2
Doddawad Vidya Gowdappa 3
Marulaiah Srinath Kenkere 4
Gowdappa Hathur Basavana 4
Shankaregowda Ranjitha 5
Madhu Basavegowda 6
Thotambailu Amulya Manohar 7
Achar Raghu Ram 8
1 Department of Anatomy, School of Public Health, JSS Medical College (A Constituent College of JSS Academy of Higher Education and Research), Mysore, Karnataka, India
2 Chief MPH Program Co-ordinator, School of Public Health, JSS Medical College (A Constituent College of JSS Academy of Higher Education and Research), Mysore, Karnataka, India
3 Department of Oral Pathology and Microbiology, JSS Dental College and Hospital (A Constituent College of JSS Academy of Higher Education and Research), Mysore, Karnataka, India
4 Department of Medicine, School of Public Health, JSS Medical College (A Constituent College of JSS Academy of Higher Education and Research), Mysore, Karnataka, India
5 Department of Microbiology, School of Public Health, JSS Medical College (A Constituent College of JSS Academy of Higher Education and Research), Mysore, Karnataka, India
6 Department of Community Medicine, School of Public Health, JSS Medical College (A Constituent College of JSS Academy of Higher Education and Research), Mysore, Karnataka, India
7 Department of Otorhinolaryngology, School of Public Health, JSS Medical College (A Constituent College of JSS Academy of Higher Education and Research), Mysore, Karnataka, India
8 Division of Biochemistry, School of Life Sciences (A Constituent College of JSS Academy of Higher Education and Research), Mysore, Karnataka, India
Address for correspondence: Dr. Vidya Gowdappa Doddawad, Department of Oral Pathology and Microbiology, JSS Dental College and Hospital (A Constituent College of JSS Academy of Higher Education and Research), Mysore - 570 022, Karnataka, India. E-mail: drvidyagd@gmail.com
2024
22 2 2024
21 1114 3 2023
12 12 2023
25 12 2023
Copyright: © 2024 Dental Research Journal
2024
https://creativecommons.org/licenses/by-nc-sa/4.0/ This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Background:

The COVID-19 pandemic which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has created a major global health crisis in recent years. Despite this, there have been few studies that have utilized reliable methods to assess changes in taste and smell perception. Therefore, our study aims at the number of fungiform papillae and objective measures of taste perception relationship among COVID-19 patients with olfactory and gustatory disorders.

Materials and Methods:

This was a cross-sectional analytical study in which 57 COVID-19 patients were recruited who confirmed the dysfunction of taste and smell. Objective assessment of the sense of taste was evaluated using four different standardized solution preparations, and the scores were given according to the patient's statements. Digitalized quantification of fungiform papillae was counted. The data were analyzed with the Pearson's correlation coefficient using the SPSS version. 23 [Licensed JSSAHER, Mysuru, Karnataka, India], and the level of significance was set at <0.001.

Results:

In terms of altered or reduced taste and smell, male patients exhibited a higher incidence compared to females. Compared to the sour taste, a substantial number of COVID-19 patients have displayed a notable decrease in their ability to taste sweet, salty, and bitter flavors. However, a statistically significant positive correlation was observed between taste scores and fungiform papillae density (r = 0.518, P < 0.001).

Conclusion:

Our Study demonstrated that the quantitative evaluation of taste perception and the count of fungiform papillae can serve as important indicators of SARS-CoV-2 infection, and could potentially help in the early detection and treatment of COVID-19 patients, as reduced taste function is a significant marker of the disease.

Agnosia
COVID-19
dysgeusia
severe acute respiratory syndrome coronavirus 2
taste perception
==== Body
pmcINTRODUCTION

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is accountable for causing COVID-19, a viral illness that began in East Asia and quickly became a global pandemic. India has been severely affected, with more than a million cases reported. Clinical investigations have identified fever, cough, difficulty breathing, arthralgia, diarrhea, sore throat, sputum production, myalgia, headache, and rhinorrhea as the most prevalent symptoms associated with the disease.[1] The occurrence and severity of smell and taste disorders are early and reliable indicators of COVID-19. A review of existing literature suggests that the prevalence of gustatory and olfactory dysfunction varies significantly across different regions, with reported rates ranging from 5.6% to 96%.

The symptoms associated with COVID-19, comprising loss of smell and taste, are not unique to the disease and can be observed in other viral infections that affect the nervous system. A Cochrane review conducted by Struyf et al. emphasized the limited sensitivity and specificity of these symptoms for diagnosing COVID-19 and highlighted the importance of identifying more specific indicators, such as anosmia or loss of sense of smell.[2] According to Menni et al., the loss of smell and taste could potentially serve as an additional indicator of COVID-19, along with other well-established symptoms. Nonetheless, while the presence of olfactory and gustatory dysfunction may assist in the early detection of the disease, they do not seem to be dependable prognostic markers of the disease.[3]

Recent research has highlighted the potential for COVID-19 to cause smell and taste disorders. An early study in Italy reported that 33.9% of COVID-19 patients who were hospitalized experienced a loss of smell or taste. Further investigations conducted across Europe revealed even higher rates, with olfactory dysfunction occurring in 75% to 85% of patients and gustatory dysfunction affecting 70% to 88% of cases. Similarly, in the United States, a high prevalence of taste and olfactory disorders has been observed in COVID-19 patients. These findings suggest that changes in smell or taste could potentially serve as a reliable indicator of COVID-19 infection and could help in the early detection of the disease.[4]

While there has been research on the loss or reduction of smell and taste during the acute phase of SARS-CoV-2 infection and the subsequent months, there is limited understanding of the qualitative symptoms of these disorders. There have been limited studies utilizing objective measures to assess gustatory function in COVID-19 patients, leaving the underlying pathophysiological mechanisms of taste disorders following the disease unclear. To improve understanding in this area, we aimed to investigate the relationship between the number of fungiform papillae and objective measurements of taste perception in COVID-19-positive patients who have experienced gustatory and olfactory dysfunctions.

MATERIALS AND METHODS

The present cross-sectional analytical study was led in JSS Hospital Mysuru, and Ethical Committee clearance has been obtained from the Institution's Ethical Committee with reference number: JSSMC/IEC/05012022/33NCT/2020-21. COVID-19 patients as the case were selected from the COVID-19 care center based on the inclusion and exclusion criteria. From these cases, individuals aged 18–60-year-old person of either sex who tested positive for coronavirus through reverse transcription–polymerase chain reaction (RT-PCR) and exhibited dysfunction in both smell and taste, were selected. A person with a history of recent (dental treatment past 1 week) or oral diseases and ear, nose, and throat infections or other communicable/systemic diseases and any drug intake and food allergies that are known to cause alteration in taste function was excluded from the study.

Sample size

According to the medical literature, to investigate the loss of taste or smell with a relative precision of 15% and a 95% confidence interval, a minimum sample size of 57 subjects who tested positive for COVID-19 is required (with a compromise on the precision error). We recruited all eligible study participants consecutively from two COVID-19 sample collection centers until the desired sample size was reached.

After taking informed consent, the confirmed COVID-19 cases were clinically examined and interviewed, and data were collected on demographic details, general health information, vaccination information, drug intake, oral habits and diseases, systemic health, and the type of taste and smell changes in COVID-19-positive patients. Sample collection area, wearing appropriate personal protective equipment, and oral swab specimens are collected as per ICMR guidelines. Patients were asked to cleanse their mouths with water so that any debris from the oral cavity was wiped out. The tongue was dried with filter paper (Whatman No. 1). A cotton-tipped tweezer was used to apply a methylene blue-colored dye onto the anterior dorsal surface of the tongue, which is the area with the highest concentration of fungiform papillae. Then, the patient was asked to keep the tongue in a steady position and the image was taken using a 48-megapixel (f/2.0) Samsung S10 Lite Android phone. After transferring the images to a computer, a distinct number was assigned to each image to identify the corresponding patient. The computer-generated grid was overlaid onto the image, and the front 2 cm of the tongue was partitioned into eight 1 cm2 sections on each side of the tongue and then counted, as shown in Figure 1. To minimize errors, the number of fungiform papillae in each section of the tongue's image of each participant was counted twice.[5]

Figure 1 Stained anterior 2 cm of tongue divided into 8 areas using Adobe Photoshop.

Participants were instructed to sit comfortably and identify four basic tastes (bitter, sour, sweet, and salty) during the test. They were advised to abstain from consuming food and drinks (except water), smoking, or brushing their teeth for at least an hour before the test. The assessment of primary taste perception was conducted using Gupta et al.'s standardized tool.[6] The taste strips included the following concentrations and compounds: sweet (sucrose) at 0.4, 0.2, 0.1, and 0.05 g/mL; sour (citric acid) at 0.3, 0.165, 0.09, and 0.05 g/mL; salt (sodium chloride) at 0.25, 0.1, 0.04, and 0.016 g/mL; and bitter (quinine hydrochloride) at 0.006, 0.0024, 0.0009, and 0.0004 g/mL.

The filter paper strips of 8 cm in length and tip area of 2 cm2 were dipped in the respective solutions (four concentrations of each of the four basic tastes) and placed on the dorsal surface of the anterior part of the tongue as shown in Figure 2. Taste scores were estimated for each concentration of all four basic tastants. A score of 1 was awarded for correctly identifying each taste strip, and the highest attainable score for the identification of all taste strips was 16. Fresh solutions were prepared every morning and left for 3 h before being remade. The collected data were entered into an MS Excel sheet and subjected to statistical analysis.

Figure 2 The assessment of basic taste perception at the dorsal surface of the anterior part of the tongue.

Statistical analysis

Qualitative variables were articulated as frequencies and percentages, while continuous variables were expressed as mean and standard deviation. Pearson's correlation test was used to find the correlation between taste scores and fungiform density. An independent sample t-test was used to assess the mean difference of taste scores and fungiform density with gender. P <0.05 was considered statistically significant.

RESULTS

A total of 57 patients were included in the study. The study participants had a mean age of 42 ± 11.3 years (ranging from 19 to 60 years), with 34 females and 23 males included in the sample. Male patients exhibited changes, reductions, or losses in taste and smell in comparison to their female counterparts.

Table 1 shows that sweet, salty, and bitter tastes are more frequently affected by a loss of taste or changes in taste perception compared to sour taste. The mean and standard deviation of age, fungiform density, and taste scores (%) are 42 ± 11.3, 10 ± 1.4, and 11.7 ± 1.7, respectively, as shown in Table 2. There was no statistically significant difference in mean taste score (%) between males (10.18 ± 1.547) and females (9.74 ± 1.010, P = 0.202). Likewise, there was no significant difference in mean fungiform density between males (11.812 ± 1.5587) and females (11.765 ± 2.0617) (P = 0.923), as shown in Table 3. However, there was a positive correlation between taste scores and fungiform density, which is statistically significant (r = 0.518, P < 0.001), as shown in Graph 1.

Table 1 The four different types of taste perception scores between males and females among COVID-19 patients

Score	Sweet, n (%)	Salt, n (%)	Sour, n (%)	Bitter, n (%)	
1	9 (15.8)	2 (3.5)	0	2 (3.5)	
2	23 (40.4)	26 (45.6)	30 (52.6)	16 (28.1)	
3	25 (43.9)	27 (47.4)	26 (45.6)	33 (57.9)	
4	0	2 (3.5)	1 (1.8)	6 (10.5)	

Table 2 The mean, standard deviation, maximum and minimum of age, fungiform density, and taste scores among COVID-19 patients

Parameters	Mean±SD	Minimum	Maximum	
Age (year)	42±11.3	19.0	60	
Taste score (%)	10±1.363	7	12	
Fungiform density	11.793±1.7613	7.4	14.8	
SD: Standard deviation

Table 3 The fungiform density and taste score between males and females among COVID-19 patients

Parameters	Sex	n	Mean±SD	SEM	
Taste score (%)	Male	34	10.18±1.547	0.265	
	Female	23	9.74±1.010	0.211	
Fungiform density	Male	34	11.812±1.5587	0.2673	
	Female	23	11.765±2.0617	0.4299	
SD: Standard deviation; SEM: Standard error of mean

Graph 1 Correlation of fungiform papillae density and taste scores of basic tastes (sweet, salt, sour, and bitter) among COVID-19 patients.

DISCUSSION

When COVID-19 first emerged, patients often reported cough, fever, and shortness of breath as the primary symptoms. The symptom of olfactory and taste dysfunction is highly variable and one of the most commonly reported during the acute phase of COVID-19. During clinical interviews, patients often describe distorted or hallucinatory perceptions of taste, while objective tests such as strip tests are typically used to diagnose loss of taste.[78] The clinical examination with other risk factors and the association of taste alteration symptoms with fungiform papillae count has not been reported in India.

A cross-sectional analytical study was carried out to determine the incidence of smell or taste loss based on both self-reporting and clinical examination in individuals who underwent COVID-19 RT-PCR testing at sample collection centers in Mysuru city, Southern India. The study found that a significantly higher percentage of people who tested positive for COVID-19 had experienced a loss of smell or taste in comparison to those who tested negative. Out of the 57 participants who tested positive for COVID-19 in our study, 70% reported a loss of smell and 80% had a loss of taste, with 89% of them being vaccinated. Mullol et al. have noted that the prevalence of smell or taste dysfunction in individuals with COVID-19 has shown a high degree of variation, ranging from 5% to 98%, which can be attributed to differences in study methodology, research design, and country of origin.[9] Carrillo-Larco and Altez-Fernandez found that the incidence of anosmia in individuals with COVID-19 varied from 22% to 68%, while the incidence of taste disorders ranged from 20% to 33%.[10] Samaranayake et al. conducted a meta-analysis on 11,054 COVID-19 patients across eight studies and estimated that 74.9% of mild-to-severe cases of COVID-19 patients had anosmia, while 81.3% had dysgeusia.[11] As part of a European Multicenter study, Lechien et al. discovered that among 417 patients, olfactory dysfunction was reported among 85.6% while 88.0% reported experiencing gustatory dysfunction.[1] Jeyashree et al. reported that in patients with mild-to-moderate symptoms, the prevalence of self-reported alterations in the sense of smell or taste was 67%, while in patients with severe symptoms, it was 31%.[12]

The present study showed that the mean age of patients was 42 ± 11.3 years (range: 19–60). There were 34 females and 23 males. According to Yadav et al., the average age of their study population was 43.03 ± 16.10 years, with 51.3% being male and 48.7% being female.[13] However, in studies conducted by Lechien et al. and Klopfenstein et al., a higher incidence of gustatory and olfactory dysfunction was reported in female patients at 63% and 67%, respectively.[114]

Several studies have indicated that there may be a gender-based bias in the development of chemosensory dysfunctions, possibly due to differences in the inflammatory response process between males and females. In a study by Kavaz et al., it was found that males exhibited a notably higher degree of dysfunction in their ability to smell and taste.[7] However, the present study revealed a significantly higher impairment of taste and smell in males when compared to females. However, there was no significant mean difference in taste score between males (10.18 ± 1.547) and females (9.74 ± 1.010, P = 0.202). There was no significant mean difference in fungiform density between males (11.812 ± 1.5587) and females (11.765 ± 2.0617) (P = 0.923). However, there was a positive correlation between taste scores and fungiform density, which is statistically significant (r = 0.518, P < 0.001).

The prevalence of taste disorders in individuals with COVID-19 was examined by Hintschich et al. through the application of the taste strip test, which yielded a rate of 28%.[15] In another study by Singer-Cornelius et al., who used Burghart taste strips to evaluate the sense of taste, the authors found the rate of taste impairment as 25% and reported that this loss was mostly in sour and salty tastes.[16] Kaya et al. found the most significant loss of taste in salty (27%) and sour (6%) tastes.[17] However, we found that sweet, salty, and bitter tastes are more frequently affected by changes in taste perception compared to sour tastes.

Objective gustatory assessments reveal a significantly higher prevalence of gustatory dysfunction compared to subjective measures, which may underestimate the true prevalence. Given the importance of gustatory and olfactory dysfunctions as symptoms of COVID-19, it has become necessary to investigate this area to understand the disease's pathophysiology. The neural-mucosal interface may be infiltrated by SARS-CoV-2 through transmucosal entry via regional nervous structures. If the virus gains entry into the brain, it may persist for years and induce inflammation, potentially leading to chronic neurological illnesses. The angiotensin-converting enzyme 2 (ACE2) receptor, which assists SARS-CoV-2 invasion, is found in both the olfactory neuroepithelium and the taste buds. Furthermore, an inflammatory response caused by cytokine release following ACE2 receptor binding has been proposed. Despite being more practical, subjective assessments may result in an underestimate of the prevalence of gustatory dysfunction.[18]

As far as we know, this study is one of the limited research carried out in India that has reported on the frequency of smell and taste loss in people impacted by COVID-19. We have utilized both subjective and objective assessments of taste, along with digital measurement of fungiform papillae, to confirm the loss of taste. Furthermore, the individuals being examined were unaware of their COVID-19 status, which ensured that their responses were not influenced by a positive test result. Hence, our estimates are potentially more precise. The taste solutions used in the study were chosen to be prepared appropriately for the target population and can be standardized across the country using the same concentrations.

Strength of the study

Our study has the notable feature of being prospective and conducted on a real cohort of COVID-19 patients in the Indian population. This is because all patients who tested positive for COVID-19 via RT-PCR were admitted to our hospital, regardless of the presence or absence of symptoms.

Limitation of the study

The assessment of taste sensation through clinical examination still involves a subjective element, as it relies on the participant's responses. We did not attempt to account for this bias by including a control population in our study. Additionally, our study was limited to COVID-19 patients who reported a loss of taste and smell, and we did not include all hospitalized patients being tested for the virus. As a result, we were unable to investigate the duration of the symptoms or examine the relationship between these symptoms and other risk factors, disease severity, or infection outcomes. Additionally, the number of individuals reporting these symptoms was relatively small, making it difficult to conclude. To determine whether psychophysical tests and taste dysfunction can detect subclinical dysgeusia in high-risk populations, further research is needed.

As far as we are aware, this is the first single-center cohort study in India to assess fungiform papillae count and gustatory dysfunction in COVID-19 patients with confirmed diagnoses. This could offer clinicians and dietitians a systematic approach to managing COVID-19 patients in a clinical setting.

CONCLUSION

The study of identifying and assessing the fungiform papillae density and correlating it with taste scores proved to be a noninvasive tool. As there is a strong correlation between fungiform papillae density and taste scores, this study gives a roadmap for dieticians and clinicians to promote successful guidance and management for better health care. Therefore, taste and/or smell impairment is now considered an important symptom and biomarker when screening for COVID-19.

Financial support and sponsorship

Nil.

Conflicts of interest

The authors of this manuscript declare that they have no conflicts of interest, real or perceived, financial or nonfinancial in this article.
==== Refs
REFERENCES

1. Lechien JR Chiesa-Estomba CM De Siati DR Horoi M Le Bon SD Rodriguez A Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): A multicenter European study Eur Arch Otorhinolaryngol 2020 277 2251 61 32253535
2. Struyf T Deeks JJ Dinnes J Takwoingi Y Davenport C Leeflang MM Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease Cochrane Database Syst Rev 2020 7 CD013665 32633856
3. Menni C Valdes AM Freidin MB Sudre CH Nguyen LH Drew DA Real-time tracking of self-reported symptoms to predict potential COVID-19 Nat Med 2020 26 1037 40 32393804
4. Song J Deng YK Wang H Wang ZC Liao B Ma J Self-reported taste and smell disorders in patients with COVID-19: Distinct features in China Curr Med Sci 2021 41 14 23 33582900
5. Rao A Vidya CS Smitha MC Vidya GD Digital image quantification of fungiform papillae to assess decreased taste sensation among geriatric patients J Morphol Sci 2022 39 66 70
6. Gupta N Rai R Garg S Taneja HC Bhatia MS Vaid L Taste function and salivary analysis in patients with oral sensorial complaints Indian J Oral Health Res 2019 5 17 22
7. Kavaz E Tahir E Bilek HC Kemal Ö Deveci A Aksakal Tanyel E Clinical significance of smell and taste dysfunction and other related factors in COVID-19 Eur Arch Otorhinolaryngol 2021 278 2327 36 33386439
8. Ercoli T Masala C Pinna I Orofino G Solla P Rocchi L Qualitative smell/taste disorders as sequelae of acute COVID-19 Neurol Sci 2021 42 4921 6 34557966
9. Mullol J Alobid I Mariño-Sánchez F Izquierdo-Domínguez A Marin C Klimek L The loss of smell and taste in the COVID-19 outbreak: A tale of many countries Curr Allergy Asthma Rep 2020 20 61. 32748211
10. Carrillo-Larco RM Altez-Fernandez C Anosmia and dysgeusia in COVID-19: A systematic review Wellcome Open Res 2020 May 13 5 94 32587902
11. Samaranayake LP Fakhruddin KS Panduwawala C Sudden onset, acute loss of taste and smell in coronavirus disease 2019 (COVID-19): a systematic review Acta Odontol Scand 2020 Aug 78 6 467 473 32762282
12. Jeyashree K Raju M Ponnaiah M Muthappan S Rozario AG Raichel R Self-reported and clinically identified loss of smell and taste among persons tested for COVID-19 in Chennai, Southern India, July-August 2020: A cross sectional study Clin Epidemiol Glob Health 2021 11 100718. 33754133
13. Yadav V Bhagat S Sharma DK Sibia RP Pandav R Sandhu VP Olfactory and gustatory dysfunction in COVID-19 patients: A tertiary care institute experience in India Indian J Otolaryngol Head Neck Surg 2022 74 2801 8 33425695
14. Klopfenstein T Kadiane-Oussou NJ Toko L Royer PY Lepiller Q Gendrin V Features of anosmia in COVID-19 Med Mal Infect 2020 50 436 9 32305563
15. Hintschich CA Brosig A Hummel T Andorfer KE Wenzel JJ Bohr C Gustatory function in acute COVID-19 – Results from home-based psychophysical testing Laryngoscope 2022 132 1082 7 35188975
16. Singer-Cornelius T Cornelius J Oberle M Metternich FU Brockmeier SJ Objective gustatory and olfactory dysfunction in COVID-19 patients: A prospective cross-sectional study Eur Arch Otorhinolaryngol 2021 278 3325 32 33471170
17. Kaya A Altıparmak S Yaşar M Özcan İ Çelik İ Objective evaluation of smell and taste senses in COVID-19 patients Turk Arch Otorhinolaryngol 2022 60 128 33 36452244
18. Cao AC Nimmo ZM Mirza N Cohen NA Brody RM Doty RL Objective screening for olfactory and gustatory dysfunction during the COVID-19 pandemic: A prospective study in healthcare workers using self-administered testing World J Otorhinolaryngol Head Neck Surg 2021 8 249 56 33614178
